Interestingly, treatment with either the antiplatelet agent aspirin or the P2X7 inhibitor or NEK7 knockdown corrected oleatic acid + ATP-induced exacerbations of mitochondrial fragmentation and lipid accumulation in hepatocytes or ameliorated MASLD in mice. Here, P2RX7 is linked to metabolic dysfunction-associated steatotic liver disease.